BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34932116)

  • 1. A Novel Eye Drop Formulation for Potential Treatment of Neovascular Age-Related Macular Degeneration.
    Huang WC; Cheng F; Chen CC; Kuo PH; Wang YJ; Yin SC; Tu CM; Wu MH; Wang WY; Chen SE
    Transl Vis Sci Technol; 2021 Dec; 10(14):23. PubMed ID: 34932116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Species differences in ocular pharmacokinetics and pharmacological activities of regorafenib and pazopanib eye-drops among rats, rabbits and monkeys.
    Horita S; Watanabe M; Katagiri M; Nakamura H; Haniuda H; Nakazato T; Kagawa Y
    Pharmacol Res Perspect; 2019 Dec; 7(6):e00545. PubMed ID: 31763044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical noninvasive retinal drug delivery of a tyrosine kinase inhibitor: 3% cediranib maleate cyclodextrin nanoparticle eye drops in the rabbit eye.
    Lorenzo-Soler L; Praphanwittaya P; Olafsdottir OB; Kristinsdottir IM; Asgrimsdottir GM; Loftsson T; Stefansson E
    Acta Ophthalmol; 2022 Nov; 100(7):788-796. PubMed ID: 35080812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical Delivery of Anti-VEGF Drugs to the Ocular Posterior Segment Using Cell-Penetrating Peptides.
    de Cogan F; Hill LJ; Lynch A; Morgan-Warren PJ; Lechner J; Berwick MR; Peacock AFA; Chen M; Scott RAH; Xu H; Logan A
    Invest Ophthalmol Vis Sci; 2017 May; 58(5):2578-2590. PubMed ID: 28494491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Long-Lasting Potential of Suprachoroidal Axitinib Suspension Via Ocular and Systemic Disposition in Rabbits.
    Kansara VS; Muya LW; Ciulla TA
    Transl Vis Sci Technol; 2021 Jun; 10(7):19. PubMed ID: 34128964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of topical ocular nepafenac and its active metabolite amfenac to the posterior segment of the eye.
    Chastain JE; Sanders ME; Curtis MA; Chemuturi NV; Gadd ME; Kapin MA; Markwardt KL; Dahlin DC
    Exp Eye Res; 2016 Apr; 145():58-67. PubMed ID: 26474497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical Ophthalmic Liposomes Dual-Modified with Penetratin and Hyaluronic Acid for the Noninvasive Treatment of Neovascular Age-Related Macular Degeneration.
    Sun C; Zhang S; Xu N; Liu K; Wei F; Zhang X; Zhang J; Gao S; Yu Y; Ding X
    Int J Nanomedicine; 2024; 19():1887-1908. PubMed ID: 38414529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of TAK-593 Ophthalmic Emulsion for the Treatment of Age-Related Macular Degeneration.
    Mori Y; Yamamoto A; Nakagawa A; Hikima T; Isowaki A
    Biol Pharm Bull; 2023 Jul; 46(7):921-928. PubMed ID: 37164692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular tissue distribution and pharmacokinetic study of a small 13kDa domain antibody after intravitreal, subconjuctival and eye drop administration in rabbits.
    Gough G; Szapacs M; Shah T; Clements P; Struble C; Wilson R
    Exp Eye Res; 2018 Feb; 167():14-17. PubMed ID: 29074387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration.
    Eyetech Study Group
    Retina; 2002 Apr; 22(2):143-52. PubMed ID: 11927845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-Dimensional Transport Model for Intravitreal and Suprachoroidal Drug Injection.
    Zhang Y; Bazzazi H; Lima E Silva R; Pandey NB; Green JJ; Campochiaro PA; Popel AS
    Invest Ophthalmol Vis Sci; 2018 Oct; 59(12):5266-5276. PubMed ID: 30383198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of a New Nanostructured Microemulsion System for Ocular Delivery of Sorafenib to Posterior Segment of the Eye.
    Santonocito M; Zappulla C; Viola S; La Rosa LR; Solfato E; Abbate I; Tarallo V; Apicella I; Platania CBM; Maugeri G; D'Agata V; Bucolo C; De Falco S; Mazzone MG; Giuliano F
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting retinal and choroid neovascularization using the small molecule inhibitor carboxyamidotriazole.
    Afzal A; Caballero S; Palii SS; Jurczyk S; Pardue M; Geroski D; Edelhauser H; Hochhaus G; Kim M; Franklin A; Shapiro G; Grant MB
    Brain Res Bull; 2010 Feb; 81(2-3):320-6. PubMed ID: 19679174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and pharmacokinetics of intravitreal 2-methoxyestradiol implants in normal rabbit and pharmacodynamics in a rat model of choroidal neovascularization.
    Robinson MR; Baffi J; Yuan P; Sung C; Byrnes G; Cox TA; Csaky KG
    Exp Eye Res; 2002 Feb; 74(2):309-17. PubMed ID: 11950241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful Proof-of-Concept for Topical Delivery of Novel Peptide ALM201 with Potential Usefulness for Treating Neovascular Eye Disorders.
    Obasanmi G; Nesbit MA; Cobice D; Mackay L; McGimpsey S; Wappett M; Cranston AN; Moore TCB
    Ophthalmol Sci; 2022 Jun; 2(2):100150. PubMed ID: 36249680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eye Drop with Fas-Blocking Peptide Attenuates Age-Related Macular Degeneration.
    Yi Y; Pyun SH; Kim CY; Yun G; Kang E; Heo S; Ullah I; Lee SK
    Cells; 2024 Mar; 13(6):. PubMed ID: 38534392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-angiogenic effects of the receptor tyrosine kinase inhibitor, pazopanib, on choroidal neovascularization in rats.
    Yafai Y; Yang XM; Niemeyer M; Nishiwaki A; Lange J; Wiedemann P; King AG; Yasukawa T; Eichler W
    Eur J Pharmacol; 2011 Sep; 666(1-3):12-8. PubMed ID: 21620822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular biodistribution of bevasiranib following a single intravitreal injection to rabbit eyes.
    Dejneka NS; Wan S; Bond OS; Kornbrust DJ; Reich SJ
    Mol Vis; 2008 May; 14():997-1005. PubMed ID: 18523657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and posterior segment biodistribution of ESBA105, an anti-TNF-alpha single-chain antibody, upon topical administration to the rabbit eye.
    Furrer E; Berdugo M; Stella C; Behar-Cohen F; Gurny R; Feige U; Lichtlen P; Urech DM
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):771-8. PubMed ID: 18757508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclodextrin microparticles for drug delivery to the posterior segment of the eye: aqueous dexamethasone eye drops.
    Loftsson T; Hreinsdóttir D; Stefánsson E
    J Pharm Pharmacol; 2007 May; 59(5):629-35. PubMed ID: 17524227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.